Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms

Heart Rate Recovery and Oxygen Kinetics After Exercise in Obstructive Sleep Apnea Syndrome

(2010) Serafim Nanas et al.   CLINICAL CARDIOLOGY

Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes–focus on venlafaxine and O-desmethylvenlafaxine

(2010) Mani Kandasamy et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin–norepinephrine reuptake inhibitor Venlafaxine

(2010) Marian Christoph et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effect of Cytochrome P450 Enzyme Polymorphisms on Pharmacokinetics of Venlafaxine

(2010) Donald E McAlpine et al.   THERAPEUTIC DRUG MONITORING

Venlafaxine Induced Acute Myocardial Infarction With Normal Coronary Arteries

(2009) Darshan Godkar et al.   AMERICAN JOURNAL OF THERAPEUTICS

Electrocardiogram changes and arrhythmias in venlafaxine overdose

(2009) Geoffrey K. Isbister   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Fatal cardiotoxicity induced by venlafaxine overdosage

(2009) Jonas Höjer et al.   CLINICAL TOXICOLOGY